Cargando…

Pravastatin reduces radiation-induced damage in normal tissues

Pravastatin is an inhibitor of 3-hydroxy-3-methyl- glutaryl-coenzyme A reductase that has been reported to have therapeutic applications in a range of inflammatory conditions. The aim of the present study was to assess the radioprotective effects of pravastatin in an experimental animal model. Mice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doi, Hiroshi, Matsumoto, Seiji, Odawara, Soichi, Shikata, Toshiyuki, Kitajima, Kazuhiro, Tanooka, Masao, Takada, Yasuhiro, Tsujimura, Tohru, Kamikonya, Norihiko, Hirota, Shozo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443166/ https://www.ncbi.nlm.nih.gov/pubmed/28565765 http://dx.doi.org/10.3892/etm.2017.4192

Ejemplares similares

Polaprezinc protects normal intestinal epithelium against exposure to ionizing radiation in mice
por: Odawara, Soichi, et al.
Publicado: (2016)

Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy
por: DOI, HIROSHI, et al.
Publicado: (2014)

Low-Dose Aspirin Therapy Does not Increase the Severity of Acute Radiation Proctitis
por: Doi, Hiroshi, et al.
Publicado: (2012)

Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer
por: Doi, Hiroshi, et al.
Publicado: (2013)

Corrigendum to ‘Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer’(†)
por: Doi, Hiroshi, et al.
Publicado: (2014)

Dosimetric and delivery characterizations of full-arc and half-arc volumetric-modulated arc therapy for maxillary cancer
por: Miura, Hideharu, et al.
Publicado: (2012)

Three-dimensional radiochromic film dosimetry for volumetric modulated arc therapy using a spiral water phantom
por: Tanooka, Masao, et al.
Publicado: (2013)

The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases
por: Fujiwara, Masayuki, et al.
Publicado: (2015)

Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma
por: Doi, Hiroshi, et al.
Publicado: (2018)

The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy
por: Yoshikawa, Reigetsu, et al.
Publicado: (2012)

Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

(11)C-Choline positive but (18)F-FDG negative pancreatic metastasis from renal cell carcinoma on PET
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models
por: Balan, Adelina, et al.
Publicado: (2017)

Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)
por: Hasegawa, Seiki, et al.
Publicado: (2015)

Neuroprotective effects of pravastatin in cerebral venous infarction in a rat model
por: Sato, Fumiya, et al.
Publicado: (2023)

Effect of Pravastatin on Echocardiographic Circulation Parameters in Dogs
por: ARITA, Shinji, et al.
Publicado: (2013)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
por: Salna, Michael P., et al.
Publicado: (2017)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
por: Csomó, Krisztián, et al.
Publicado: (2022)

The Potential Use of 11C-Choline Positron Emission Tomography/Computed Tomography to Monitor the Treatment Effects of Radium-223 in a Patient with Prostate Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma
por: Hashimoto, Masaki, et al.
Publicado: (2022)

Effect of pravastatin on the survival of patients with advanced gastric cancer
por: Bujanda, Luis, et al.
Publicado: (2015)

Pravastatin for prevention of HELLP syndrome: A case report
por: Otten, Lucia Anna, et al.
Publicado: (2017)

Pravastatin in preeclampsia: A meta-analysis and systematic review
por: Mészáros, Balázs, et al.
Publicado: (2023)

Effects of pravastatin on the pharmacokinetic parameters of nimodipine after oral and intravenous administration in rats: Possible role of CYP3A4 inhibition by pravastatin
por: Lee, Chong-Ki, et al.
Publicado: (2012)

Pravastatin Use and the Five-year Incidence of Cancer in Coronary Heart Disease Patients: from the Prevention of Coronary Sclerosis Study
por: Sato, Shinichi, et al.
Publicado: (2006)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)

Pravastatin Provides Antioxidant Activity and Protection Of Erythrocytes Loaded Primaquine
por: Alanazi, Fars
Publicado: (2010)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products
por: Ruiz-Picazo, Alejandro, et al.
Publicado: (2019)

Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia Management
por: Saraogi, Gaurav Kant, et al.
Publicado: (2022)

Computation-Aided Engineering of Cytochrome P450 for the Production of Pravastatin
por: Ashworth, Mark A., et al.
Publicado: (2022)

Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats
por: Nozaki, Yoshihiro, et al.
Publicado: (2012)

Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat
por: Herring, Neil, et al.
Publicado: (2011)

Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin
por: Asanuma, Yu, et al.
Publicado: (2008)

Pravastatin-induced proangiogenic effects depend upon extracellular FGF-2
por: Shiota, Masayuki, et al.
Publicado: (2012)

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy
por: Takazakura, Akiko, et al.
Publicado: (2015)

Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk
por: Drewes, Yvonne M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_740n9379p7n9tmhl86tm0678ti